Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference
Cocrystal Pharma (NASDAQ: COCP) has announced its participation in the Noble Capital Markets' 2025 Emerging Growth Virtual Equity Conference. The company's management will engage in a fireside chat on Thursday, June 5, 2025, at 12:00 p.m. Eastern time.
The event will feature a live Q&A session, and qualified investors can request one-on-one meetings with management through the conference platform. A video webcast of the presentation will be available within 48 hours on both the Cocrystal website and Channelchek, where it will remain accessible for 90 days.
Cocrystal Pharma (NASDAQ: COCP) ha annunciato la sua partecipazione alla conferenza virtuale 2025 Emerging Growth organizzata da Noble Capital Markets. Il management dell'azienda parteciperà a una discussione informale il giovedì 5 giugno 2025, alle 12:00 ora orientale.
L'evento includerà una sessione di domande e risposte in diretta, e gli investitori qualificati potranno richiedere incontri individuali con il management tramite la piattaforma della conferenza. Una registrazione video della presentazione sarà disponibile entro 48 ore sia sul sito web di Cocrystal che su Channelchek, dove resterà accessibile per 90 giorni.
Cocrystal Pharma (NASDAQ: COCP) ha anunciado su participación en la Conferencia Virtual de Acciones de Crecimiento Emergente 2025 de Noble Capital Markets. La dirección de la compañía participará en una charla informal el jueves 5 de junio de 2025 a las 12:00 p.m. hora del Este.
El evento contará con una sesión de preguntas y respuestas en vivo, y los inversores calificados podrán solicitar reuniones individuales con la dirección a través de la plataforma de la conferencia. Una transmisión en video de la presentación estará disponible dentro de las 48 horas tanto en el sitio web de Cocrystal como en Channelchek, donde permanecerá accesible durante 90 días.
Cocrystal Pharma (NASDAQ: COCP)는 Noble Capital Markets의 2025 신흥 성장 가상 주식 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 6월 5일 목요일 동부 시간 오후 12시에 화상 대화에 참여할 예정입니다.
행사에는 실시간 질의응답 세션이 포함되며, 자격을 갖춘 투자자들은 컨퍼런스 플랫폼을 통해 경영진과 일대일 미팅을 요청할 수 있습니다. 발표 영상은 48시간 이내에 Cocrystal 웹사이트와 Channelchek에서 제공되며, 90일 동안 시청할 수 있습니다.
Cocrystal Pharma (NASDAQ : COCP) a annoncé sa participation à la conférence virtuelle Emerging Growth 2025 organisée par Noble Capital Markets. La direction de l'entreprise participera à une discussion informelle le jeudi 5 juin 2025 à 12h00, heure de l'Est.
L'événement comprendra une session de questions-réponses en direct, et les investisseurs qualifiés pourront demander des rencontres individuelles avec la direction via la plateforme de la conférence. Une vidéo de la présentation sera disponible dans les 48 heures sur le site web de Cocrystal et sur Channelchek, où elle restera accessible pendant 90 jours.
Cocrystal Pharma (NASDAQ: COCP) hat seine Teilnahme an der Virtuellen Emerging Growth Equity-Konferenz 2025 von Noble Capital Markets angekündigt. Das Management des Unternehmens wird am Donnerstag, den 5. Juni 2025, um 12:00 Uhr Eastern Time an einem Gespräch teilnehmen.
Die Veranstaltung beinhaltet eine Live-Fragerunde, und qualifizierte Investoren können über die Konferenzplattform Einzelgespräche mit dem Management anfragen. Eine Videoaufzeichnung der Präsentation wird innerhalb von 48 Stunden sowohl auf der Cocrystal-Website als auch auf Channelchek verfügbar sein und dort für 90 Tage abrufbar bleiben.
- None.
- None.
BOTHELL, Wash., May 28, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that management will participate in a fireside chat during the Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference on Thursday, June 5, 2025 at 12:00 p.m. (noon) Eastern time (9:00 a.m. Pacific time). Investors and interested individuals can register for the conference here. Questions from the audience during the live fireside chat will be welcomed.
Registered, qualified investors can request one-on-one meetings with Cocrystal management through the conference registration platform.
A video webcast of the presentation will be available within approximately 48 hours following the event on the Cocrystal website, and as part of a complete catalog of presentations available on Channelchek, the investor portal created by Noble. The webcast will be archived on the Company’s website and on Channelchek.com for 90 days following the event.
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of noroviruses, influenza viruses, coronaviruses (including SARS-CoV-2), and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.
Contact:
Alliance Advisors IR
Jody Cain
310-691-7100
jcain@allianceadvisors.com
# # #
FAQ
When is Cocrystal Pharma (COCP) presenting at the Noble Capital Markets Conference 2025?
How can investors access Cocrystal Pharma's (COCP) Noble Conference presentation?
How long will Cocrystal Pharma's (COCP) Noble Conference presentation be available for viewing?
Can investors meet with Cocrystal Pharma's (COCP) management during the Noble Conference?
